| Nome |
# |
|
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2 receptor antagonists/inverse agonists, file e1dc1a2d-df73-1507-e053-3a05fe0ac7a3
|
43
|
|
Tricyclic Pyrazoles. Part 8. Synthesis, Biological Evaluation and Modelling of Tricyclic Pyrazole Carboxamides as Potential CB2 Receptor Ligands with Antagonist/Inverse Agonist Properties., file e1dc1a2d-cac9-1507-e053-3a05fe0ac7a3
|
16
|
|
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking, file e1dc1a2d-dca6-1507-e053-3a05fe0ac7a3
|
14
|
|
Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: novel selective ligands with subnanomolar affinity for α4β2 nACh receptorS, file e1dc1a2d-d389-1507-e053-3a05fe0ac7a3
|
12
|
|
Synthesis and pharmacological activity of 4-carbamoyl-6-beta-thienyl-4,5-dihydropyridazin-3-(2H)ones, file e1dc1a2d-088a-1507-e053-3a05fe0ac7a3
|
11
|
|
N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as μ-opioid receptor agonists. Effects on μ-affinity of arylalkenyl chain modifications, file e1dc1a2a-4e91-1507-e053-3a05fe0ac7a3
|
10
|
|
Pharmaceutical compounds, file e1dc1a2a-6409-1507-e053-3a05fe0ac7a3
|
10
|
|
Composti farmaceutici, file e1dc1a2a-6401-1507-e053-3a05fe0ac7a3
|
8
|
|
Chromophore-modified bis-benzo[g]indazole carboxamides: synthesis and antiproliferactive activity of bis-benzo[g]indazole carboxamides and related dimers, file e1dc1a2a-589c-1507-e053-3a05fe0ac7a3
|
5
|
|
A liquid chromatography-mass spectrometry study on the spirocyclization of ninhydrin with the aminothiols, file e1dc1a2c-3076-1507-e053-3a05fe0ac7a3
|
5
|
|
Pirazoli triciclici: sintesi e valutazione biologica di ligandi
per i recettori cannabinoidei con struttura
diidroindenopirazolica contenenti differenti sostituenti
carbossammidici, file e1dc1a2d-05da-1507-e053-3a05fe0ac7a3
|
5
|
|
Chromophore-modified bis-benzo[g]indolecarboxamides: synthesis and
citotoxicity of bis-benzo[g]indazole-3-carboxamides and related compounds, file e1dc1a2d-07e1-1507-e053-3a05fe0ac7a3
|
5
|
|
Sintesi di nuovi leganti chirali dipiridilmetanici e loro applicazione nella
sostituzione allilica palladio-catalizzata, file e1dc1a2d-0846-1507-e053-3a05fe0ac7a3
|
5
|
|
Application of an unusual ninhydrin-based reaction for the indirect chiral resolution of D,L-penicillamine, file e1dc1a2a-6434-1507-e053-3a05fe0ac7a3
|
4
|
|
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2 receptor antagonists/inverse agonists, file e1dc1a2c-a2a4-1507-e053-3a05fe0ac7a3
|
4
|
|
Sintesi di 1,10-fenantroline chirali a simmetria C2derivati da
monoterpeni naturali quali utili leganti per la catalisi asimmetrica, file e1dc1a2d-05d8-1507-e053-3a05fe0ac7a3
|
4
|
|
I 3,6-diazabiciclo[3.1.1]eptani: una nuova serie di potenti
agonisti per i recettori µ degli oppioidi, file e1dc1a2d-066a-1507-e053-3a05fe0ac7a3
|
4
|
|
Unexpected reversal of the enantioselectivity using chiral quinolylmethyl- and acridininyloxazokines as ligands for asymmetric palladium-catalyzed allylic alkylation, file e1dc1a2d-07e6-1507-e053-3a05fe0ac7a3
|
4
|
|
Tricyclic pyrazoles: synthesis and biological evaluation of novel 4,5-dihydrobenzo-1h-6-oxa-cyclohepta[1,2-c] pyrazole-based analogues of the cannabinoid antagonist ness 0327, file e1dc1a2d-0a42-1507-e053-3a05fe0ac7a3
|
4
|
|
Novel diazabicycloalkane delta opioid agonists, file e1dc1a2a-3f60-1507-e053-3a05fe0ac7a3
|
3
|
|
Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazoles: A versatile architecture for CB2 selective ligands, file e1dc1a2a-4073-1507-e053-3a05fe0ac7a3
|
3
|
|
Addition reactions of acetylenic esters to 6,7-dihydrobenzo[b]furan-4-(5H)-one, 6,7-dihydroindol-4(5H)-one, 5,6-dihydrobenzo[b]furan-7(6H)-one and 5,6-dihydroindol-7(6H)-one ketoximes. Formation of reduced furo[g]- and pyrrole[g]indoles, file e1dc1a2b-e12e-1507-e053-3a05fe0ac7a3
|
3
|
|
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles, file e1dc1a2c-1481-1507-e053-3a05fe0ac7a3
|
3
|
|
Synthesis and D2-like binding affinity of new derivatives of N3-[(1-
ethyltetrahydro-1H-2-pyrrolyl)methyl]-4,5-dihydrobenzo[g]indole-3-
carboxamide and related compounds, file e1dc1a2c-fd35-1507-e053-3a05fe0ac7a3
|
3
|
|
Multitarget-directed tricyclic pyridazinones as G protein-coupled receptor ligands and cholinesterase inhibitors, file e1dc1a2a-3b77-1507-e053-3a05fe0ac7a3
|
2
|
|
Chiral pyridine N-oxides derived from monoterpenes as organocatalysts for stereoselective reactions with allyltrichlorosilane and tetrachlorosilane, file e1dc1a2a-3e8f-1507-e053-3a05fe0ac7a3
|
2
|
|
Chiral pyridine N-oxides useful ligands for asymmetric catalysis, file e1dc1a2a-446b-1507-e053-3a05fe0ac7a3
|
2
|
|
Ex vivo impact of functionalized carbon nanotubes on human immune cells, file e1dc1a2a-459a-1507-e053-3a05fe0ac7a3
|
2
|
|
Synthesis and application of new iminopyridine ligands toenantioselective copper(II)-catalyzed Henry reaction, file e1dc1a2a-4750-1507-e053-3a05fe0ac7a3
|
2
|
|
Pyridazine N-Oxides. III. Synthesis and “in vitro” antimicrobial properties of N-Oxide derivatives based on tricyclic indeno[2,1-c]pyridazine and benzo [f]cinnoline systems, file e1dc1a2a-4b93-1507-e053-3a05fe0ac7a3
|
2
|
|
Synthesis of 4-(diphenylphosphanylmethyl)- and 4-(phenylthiomethyl)-1,4-methano-11,11-dimethyl-1,2,3,4-tetrahydroacridine: new N-P and N-S camphor-derived chiral ligands for asymmetric catalysis, file e1dc1a2a-50ca-1507-e053-3a05fe0ac7a3
|
2
|
|
Tricyclic pyrazoles. An Efficient approach to cannabinoid analogues with a tricyclic framework incorporating the pyrrole and pyrazole moieties, file e1dc1a2a-54bb-1507-e053-3a05fe0ac7a3
|
2
|
|
Pyrazole derivatives having affinity for CB1 and/or CB2 receptors, file e1dc1a2a-6406-1507-e053-3a05fe0ac7a3
|
2
|
|
Synthesis and D-2-like binding affinity of 4,5-dihydro-1H-benzo[g]indole-3-carboxamide derivatives as conformationally restricted 5-phenyl-pyrrole-3-carboxamide analogs, file e1dc1a2a-a37f-1507-e053-3a05fe0ac7a3
|
2
|
|
The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism, file e1dc1a2c-94a5-1507-e053-3a05fe0ac7a3
|
2
|
|
Nuovi leganti chirali di tipo P-N: sintesi ed applicazione in catalisi asimmetrica della (2R, 4R)-2,4-metano-3,3-dimetil-5-(difenilfosfanil)-1,2,3,4-tetraidroacridina, file e1dc1a2d-0b5b-1507-e053-3a05fe0ac7a3
|
2
|
|
Sintesi stereoselettiva di piridilammine, file e1dc1a2d-0b5d-1507-e053-3a05fe0ac7a3
|
2
|
|
Thienocinnolinone alkanoic acid derivatives as aldose reductase inhibitors, file e1dc1a2a-3a61-1507-e053-3a05fe0ac7a3
|
1
|
|
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for the opioid receptors, file e1dc1a2a-3e16-1507-e053-3a05fe0ac7a3
|
1
|
|
Synthesis and cytotoxicity of novel hexahydrothienocyclohepta-pyridazinone derivatives, file e1dc1a2a-3e26-1507-e053-3a05fe0ac7a3
|
1
|
|
Synthesis and in vitro anticancer activity evaluation of biscarbamic esters of 2,3-bis(hydroxymethyl)-1-methyl-7- and 7,8-substituted- benzo[g]indoles, file e1dc1a2a-3eba-1507-e053-3a05fe0ac7a3
|
1
|
|
Synthesis of regiospecifically substituted quinolines from anilines, file e1dc1a2a-43c7-1507-e053-3a05fe0ac7a3
|
1
|
|
Alternative approaches to (Z)-1,2-bis(2-bromopyridin-3-yl)ethenes, key intermediates in the synthesis of the 1,10-phenanthroline core, file e1dc1a2a-4435-1507-e053-3a05fe0ac7a3
|
1
|
|
Synthesis, Modelling, and Antimitotic Properties of Tricyclic Systems Characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole Moiety, file e1dc1a2a-45b6-1507-e053-3a05fe0ac7a3
|
1
|
|
Chiral 8-Amino Substituted 2-Phenyl-5,6,7,8-tetrahydro-6,6-dimethylmathanoquinolines as Chiral Ligands for Enantioselective Catalysis: Palladium Catalysed Allylic Substitution and Addition of Diethylzinc to Benzaldehyde, file e1dc1a2a-4824-1507-e053-3a05fe0ac7a3
|
1
|
|
Synthesis and pharmacological activity of 4-carbamoyl-5-aryl-6-methyl-4,5-dihydropyridazin-3 (2H)-ones, file e1dc1a2a-4b83-1507-e053-3a05fe0ac7a3
|
1
|
|
Chiral P,N-ligands with pyridine-nitrogen and phosphorus donor atoms. Syntheses and applications in asymmetric catalysis, file e1dc1a2a-4efe-1507-e053-3a05fe0ac7a3
|
1
|
|
Synthesis and dopamine D2-like receptor binding affinity of substituted 5-phenyl-pyrrole-3-carboxamides, file e1dc1a2a-4f0d-1507-e053-3a05fe0ac7a3
|
1
|
|
“Enantioselective Palladium Catalyzed Allylic Substitution with 2,2'-Bipyridine Ligands, file e1dc1a2a-5524-1507-e053-3a05fe0ac7a3
|
1
|
|
Tricyclic pyrazoles. Part 5. novel 1,4-Dihydroindeno[1,2-c]pyrazole CB2 ligands using molecular hybridization based on scaffold hopping, file e1dc1a2a-6241-1507-e053-3a05fe0ac7a3
|
1
|
|
Synthesis and pharmacological evaluation of novel 4-Alkyl-5-thien-2'-yl pyrazole carboxamides, file e1dc1a2a-62d4-1507-e053-3a05fe0ac7a3
|
1
|
|
Pharmaceutical Compounds, file e1dc1a2a-6538-1507-e053-3a05fe0ac7a3
|
1
|
|
Synthesis of biologically active bridged diazabicycloheptanes, file e1dc1a2a-65ac-1507-e053-3a05fe0ac7a3
|
1
|
|
Ex vivo impact of functionalized carbon nanotubes on human immune cells, file e1dc1a2a-7788-1507-e053-3a05fe0ac7a3
|
1
|
|
Synthesis, Pharmacological Evaluation and Docking Studies of Pyrrole Structure-Based CB2 Receptor Antagonists, file e1dc1a2a-78bc-1507-e053-3a05fe0ac7a3
|
1
|
|
Regioselective Hydrodebromination of polybrominated indoles, file e1dc1a2a-811f-1507-e053-3a05fe0ac7a3
|
1
|
|
Osmium complexes in catalysis of olefin hydrogenation and isomerization, file e1dc1a2a-b018-1507-e053-3a05fe0ac7a3
|
1
|
|
Synthetic Methods for the Hydrodehalogenation of Halogenated Hetrerocycles, file e1dc1a2b-0bae-1507-e053-3a05fe0ac7a3
|
1
|
|
Synthesis and D2-like binding affinity of new derivatives of N-(1-ethyl-2-pyrrolidinylmethyl)-4,5-dihydro-1H-benzo[g]indole-3-carboxamide and related 4H-[1]Benzothiopyrano[4,3-b]pyrrole and 5,6-Dihydro-4H benzo[6,7]cyclohepta[b]pyrrole-3-carboxamide Analogues, file e1dc1a2b-36ae-1507-e053-3a05fe0ac7a3
|
1
|
|
Tricyclic pyrazoles Part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands, file e1dc1a2b-3fa7-1507-e053-3a05fe0ac7a3
|
1
|
|
Development of oxygen-bridged pyrazole-based structures as cannabinoid receptor 1 ligands, file e1dc1a2b-febd-1507-e053-3a05fe0ac7a3
|
1
|
|
Hercynine content in widely consumed commercial beverages, file e1dc1a2c-38e6-1507-e053-3a05fe0ac7a3
|
1
|
|
Synthesis, Pharmacological Evaluation, and Docking Studies of Novel Pyridazinone-Based Cannabinoid Receptor Type 2 Ligands, file e1dc1a2c-92e1-1507-e053-3a05fe0ac7a3
|
1
|
|
Novel pyrrolocycloalkylpyrazole analogues as CB1 ligands, file e1dc1a2c-a8a5-1507-e053-3a05fe0ac7a3
|
1
|
|
Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB1/CB2 Receptor Interaction, file e1dc1a2c-d6d8-1507-e053-3a05fe0ac7a3
|
1
|
| Totale |
242 |